Mitochondrial-targeted plastoquinone therapy ameliorates early onset muscle weakness that precedes ovarian cancer cachexia in mice
Luca J. Delfinis, Shahrzad Khajehzadehshoushtar, Luke D. Flewwelling…·Christopher G. R. Perry
This study shows mitochondrial-targeted plastoquinone SkQ1 reduces early muscle weakness in ovarian cancer mice by improving calcium handling and mitochondrial function, without preventing atrophy.